Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven J Cohen

Showing results (21-30 of 102) with videos related to

Pageof 11
Sort By:
Practical Radiation Oncology|March 31, 2016
Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancerTalha Shaikh, Thomas M Churilla, Pooja Monpara, et al.
Practical Radiation Oncology|June 17, 2015
Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiationLora S Wang, Talha Shaikh, Elizabeth A Handorf, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 6, 2013
Impact of preoperative therapy on patterns of recurrence in pancreatic cancerPavlos Papavasiliou, John P Hoffman, Steven J Cohen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2021
Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysisAileen Deng, Chun Wang, Steven J Cohen, et al.
Clinical Colorectal Cancer|July 31, 2014
Patterns of use and tolerance of anti-epidermal growth factor receptor antibodies in older adults with metastatic colorectal cancerEfrat Dotan, Karthik Devarajan, A James D'Silva, et al.
Practical Radiation Oncology|April 2, 2016
Dosimetric predictors of hematologic toxicity in patients undergoing concurrent gemcitabine-based chemoradiation for localized pancreatic cancerTalha Shaikh, Lora S Wang, Brian Egleston, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282Steven J Cohen, Ralph Dobelbower, Stuart Lipsitz, et al.
American Journal of Clinical Oncology|September 2, 2015
Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic CancerTalha Shaikh, Lora S Wang, Brian Egleston, et al.
Journal of Geriatric Oncology|August 23, 2015
Patterns of care and outcomes of older versus younger patients with metastatic pancreatic cancer: A Fox Chase Cancer Center experienceNamrata Vijayvergia, Efrat Dotan, Karthik Devarajan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2010
Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancersRaffit Hassan, Steven J Cohen, Martin Phillips, et al.
Pageof 11

Showing results (21-30 of 102) with videos related to

Sort By:
Pageof 11
Practical Radiation Oncology|March 31, 2016
Risk of radiation pneumonitis in patients receiving taxane-based trimodality therapy for locally advanced esophageal cancerTalha Shaikh, Thomas M Churilla, Pooja Monpara, et al.
Practical Radiation Oncology|June 17, 2015
Dose escalation with a vessel boost in pancreatic adenocarcinoma treated with neoadjuvant chemoradiationLora S Wang, Talha Shaikh, Elizabeth A Handorf, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|March 6, 2013
Impact of preoperative therapy on patterns of recurrence in pancreatic cancerPavlos Papavasiliou, John P Hoffman, Steven J Cohen, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2021
Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysisAileen Deng, Chun Wang, Steven J Cohen, et al.
Clinical Colorectal Cancer|July 31, 2014
Patterns of use and tolerance of anti-epidermal growth factor receptor antibodies in older adults with metastatic colorectal cancerEfrat Dotan, Karthik Devarajan, A James D'Silva, et al.
Practical Radiation Oncology|April 2, 2016
Dosimetric predictors of hematologic toxicity in patients undergoing concurrent gemcitabine-based chemoradiation for localized pancreatic cancerTalha Shaikh, Lora S Wang, Brian Egleston, et al.
International Journal of Radiation Oncology, Biology, Physics|July 21, 2005
A randomized phase III study of radiotherapy alone or with 5-fluorouracil and mitomycin-C in patients with locally advanced adenocarcinoma of the pancreas: Eastern Cooperative Oncology Group study E8282Steven J Cohen, Ralph Dobelbower, Stuart Lipsitz, et al.
American Journal of Clinical Oncology|September 2, 2015
Predictors of Hematologic Toxicity and Chemotherapy Dose Intensity in Patients Undergoing Chemoradiation for Pancreatic CancerTalha Shaikh, Lora S Wang, Brian Egleston, et al.
Journal of Geriatric Oncology|August 23, 2015
Patterns of care and outcomes of older versus younger patients with metastatic pancreatic cancer: A Fox Chase Cancer Center experienceNamrata Vijayvergia, Efrat Dotan, Karthik Devarajan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2010
Phase I clinical trial of the chimeric anti-mesothelin monoclonal antibody MORAb-009 in patients with mesothelin-expressing cancersRaffit Hassan, Steven J Cohen, Martin Phillips, et al.
Pageof 11